This PhD-project focus on the radiographic issues of mammographic screening, and aims to investigate how breast compression is performed in clinical practice of breast cancer screening today.
It is known that some of the chemical substances in oil can be carcinogenic. The purpose of these studies is to study the prevalence of cancer among Norwegian Offshore workers and study possible relationships between exposure from the working environment and the development of cancer.
Do cancer during pregnancy influence the prognosis? Is the risk of pregnancy and delivery complications increased for women with pregnancies after cancer? If pre-eclampsia have protective effects on the life-time risk of getting breast cancer, do breast cancer survivors with a history of pre-eclampsia have a better prognosis than those without pre-eclampsia in the past?
An international study that will investigate whether tomosynthesis is a better screening technique for breast cancer than standard digital mammography.
HPVseq is an cross-institutional research group with three the main goals, To discover HPV biomarkers, delineate HPV evolution and develop HPV detection and characterization methods.
RNA are involved in numerous cellular processes in cancer development. We are currently investigating RNA as early detection and potential screening biomarkers of cancer.
In this postdoctoral project, we will investigate whether the long-term quality of life among breast cancer survivors is better in women with breast cancer detected by screening mammography compared to women with breast cancer detected due to symptoms.
- A research project aimed at improving the efficiency and quality of the national screening program – BreastScreen Norway - by combining automatic image analysis and radiological expertise.
- A research project aimed at investigating advantages and disadvantages of integrating a machine learning system for automatic interpretation of screening mammograms in BreastScreen Norway
Presence of certain bacteria in the gut are strongly associated with colorectal cancer. This project aims to discover gut microbiota biomarkers for colorectal cancer screening.
The Nordic cancer registries have carried out a larger study to calculate the cancer incidence in the Nordic countries up through the year 2020. In this study the number of new cancer cases in Norway is estimated to increase with 42% for males and 36% for females. The escalation in cancer cases is mainly due to the ageing of the population, while a smaller part of the increase are due to an increase in risk.
NORCCAP (Norwegian Colorectal Cancer Prevention) is a randomized study on screening for colorectal cancer (CRC) and adenomatous polyps (potential precursor lesions for colorectal cancer).
A PhD project will investigate aspects of over- and underdiagnosis in BreastScreen Norway. The goal of the project is to add to what is known about the potential harms of mammographic screening.
Based on data from the "Oslo Ischemia Cohort" and The Cancer Registry of Norway, this study aim to assess relationships between physical activity, fitness and cancer.
This postdoc project will estimate the risk of developing invasive breast cancer among Norwegian women with prior benign breast disease or premalignant breast lesions, and study risk factors for progression.
Sun exposure is the most important risk factor of cutaneous melanoma, but several studies have suggested that some prescripted drugs also may play a part. This project aims to investigaste if prescripted drugs influence the risk of, and death due to cutaneous melanoma and provide better and more targeted prevention of cutaneous melanoma through the identification of high-risk persons.
The tomosynthesis studies in Bergen, the To-Be studies, are aimed at investigating whether screening with digital breast tomosynthesis is a better screening tool than standard digital mammography for BreastScreen Norway.
Cutaneous Malignant Melanoma is largely caused by exposure to ultraviolet radiation (UVR). UVR is also our main source of vitamin D,which have been associated with reduced risk of some cancers. The situation for melanoma is unclear, as both low and high vitamin D levels have been associated with increased risk.